BACOU USA INC
8-K, 1999-04-23
OPHTHALMIC GOODS
Previous: VITALCOM INC, DEF 14A, 1999-04-23
Next: HARTFORD SMALL CO HLS FUND INC, 485BPOS, 1999-04-23





                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


        Date of Report (date of earliest event reported): April 20, 1999
        -----------------------------------------------------------------

                                 BACOU USA, INC.
                                 ---------------
             (Exact name of registrant as specified in its charter)


                                    DELAWARE
                                    --------
                 (State or other jurisdiction of incorporation)


                    0-28040                         05-0470688
                    -------------------------------------------
          (Commission file number)        (IRS Employer Identification Number)


                   10 Thurber Boulevard, Smithfield, RI 02917
                   ------------------------------------------
               (Address of principal executive offices) (Zip Code)


        Registrant's telephone number, including area code: 401-233-0333
        ----------------------------------------------------------------



<PAGE>



Item 7.  Financial Statements and Exhibits

           Exhibit                           Exhibit Title
           -------                           -------------

           Exhibit 99                        Press Release dated April 20, 1999




<PAGE>


                                   SIGNATURES

Pursuant to the  requirements  of the  Securities  and Exchange Act of 1934,  as
amended,  the  Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                                          BACOU USA, INC.
                                          Registrant

                                          By:  /s/ Philip B. Barr
                                               -----------------------
                                                Philip B. Barr
                                                Executive Vice President, Chief
                                                 Operating  Officer, Chief
                                                 Financial Officer and Secretary

Dated:  April 23, 1999




                                                                      Exhibit 99


Contact:
At the Company:                               At the Financial Relations Board:
- ----------------                              ---------------------------------
401-233-0333                                  212-661-8030
Philip B. Barr                                Analyst Information: John McNamara
Chief Financial Officer                       Media Information: Alan Goldsand
Investor Relations                            General Information: Jeff Bogart

FOR IMMEDIATE RELEASE
April 20, 1999

                  BACOU USA REPORTS FIRST-QUARTER 1999 RESULTS,
           PROVIDES UPDATE ON RECENT ACQUISITION OF PERFECT FIT GLOVE

     o    Net Sales of $54.6  Million  for Q1 '99, Up 10.2% Over Q1 '98 Sales of
          $49.5 Million

     o    Q1 Earnings - Up 100.0% to $5.5  Million  from Q1 '98 Earnings of $2.7
          Million

     o    Q1 Earnings Per Share - Up 106.7% to $0.31 from Q1 '98 EPS of $0.15

     o    Pre-Charge Earnings and EPS in Q1 '98 exceeded Q1 `99


     Smithfield,  R.I., April 20, 1999 -- Bacou USA, Inc. (NYSE: BAU), a leading
manufacturer  of personal  protection  equipment,  today  reported its financial
results for the first quarter ended March 31, 1999.

     Net sales for the first quarter of 1999  increased  10.2% to $54.6 million,
compared  with 1998  first  quarter  net sales of $49.5  million.  Net sales for
Bacou's  safety  segment  increased  11.8% from  $41.1  million in 1998 to $45.9
million in 1999,  while net sales in the optical frames and instruments  segment
increased 2.5% from $8.4 million in 1998 to $8.7 million in 1999. Safety segment
sales for the 1999 quarter  included sales resulting from the acquired  business
of Howard Leight Industries for three full months,  whereas the 1998 period only
included sales for one month from this acquired business.

     Bacou's net income for the first quarter of 1999  increased to $5.5 million
from  $2.7  million  for  the  first  quarter  of  1998--up  100.0%.   Excluding
non-recurring  items (none in the 1999 period and $3.7 million in 1998  relating
to the acquisition of the company's  Howard Leight  business  unit),  net income
declined by $1.0 million from the first quarter of 1998.

     As for net income per basic and diluted share, Bacou reported $0.31 for the
first  quarter  of 1999,  up 106.7%  from  $0.15 for the first  quarter of 1998.
Excluding  non-recurring  items  (none in the 1999 period and $0.21 per share in
1998 relating to the acquisition of the company's  Howard Leight business unit),
Bacou's net income decreased $0.05 per share from the first quarter of 1998.

     "Sales results early in the quarter were  disappointing,  however,  we were
pleased to see  improving  sales  trends in March,"  said  Walter  Stepan,  Vice
Chairman,  President  and Chief  Executive  Officer of Bacou USA.  "Slower  than
anticipated  sales in the quarter  resulted from softened  demand in January and
February  as well as  changes  in our  promotional  programs,  as we  previously
announced.  For example,  we moved our uvex astrospec 3000(R) promotion from the
first to the second  quarter,  which hurt the first  quarter but should help the
second.  Considering  the year as a whole,  we believe that the  consequences of
promotional  changes will not be adverse and,  therefore,  we remain  optimistic
about our prospects for the remainder of 1999."

     "As for operating  profit,  our first quarter was negatively  influenced by
     the changes in promotional  programs,"  continued Stepan.  "Resulting lower
     sales of uvex astrospec  3000(R) eyewear had the greatest effect on year to
     year comparisons.  We had satisfying growth in sales of new eyewear styles,
     respiratory  protection  products,  hearing protection products and optical
     frames,  but  some of  these  product  lines  do not  carry  gross  margins
     sufficient  to make up for the  lost  margin  from  lower  astrospec  sales
     volume."

     Stepan went on to say:  "Bacou USA is a highly  profitable  company that is
well  positioned  to take  advantage  of the  consolidation  taking place in the
safety industry. We are well-focused on our strategy to grow by acquisition,  by
expansion of market share and by penetration of new markets. Our track record of
successfully  executing  this  strategy  over the past  three  years as a public
company speaks for itself,  and we are optimistic about achieving our 1999 goals
of record earnings and earnings per share before non-recurring items."

     Bacou also  announced  today that it expects  the  operating  margin of its
recently acquired Perfect Fit Glove business to be in a range of 10 - 12%, prior
to amortization of intangible assets, which is expected to be approximately $1.1
million  annually for 30 years.  Bacou  completed its acquisition of Perfect Fit
Glove Co., Inc. and affiliated  businesses on April 1, 1999. The company expects
pre-tax one-time adjustments associated with the transaction to approximate $1.5
million,  all of which  will be  recorded  in the  second  quarter  of 1999.  As
previously  announced,  combined annual net sales of Perfect Fit Glove Co., Inc.
and  affiliates  were  approximately  $47.3  million  for the fiscal  year ended
September 30, 1998 and Bacou expects the acquisition to be accretive to earnings
by   between   one  and  four   cents   per   share  in  1999   prior  to  these
acquisition-related non-recurring items.

     Bacou also  announced  today that it  expects to incur  approximately  $2.3
million of interest expense in 1999 (based on current interest rate projections)
in connection with the acquisition of Perfect Fit and its affiliates.  In recent
filings with the SEC, Bacou disclosed that it financed the acquisition primarily
by borrowing  $50.0 million from Banque  Nationale de Paris.  Bacou also assumed
tax-exempt  industrial  development  bond  indebtedness  of  approximately  $6.8
million.  The bank debt bears  interest at 3-month LIBOR plus 0.60% and provides
for repayment  over a seven year term.  The revenue bond carries a floating rate
of interest that was most recently set at 3.1% plus an annual credit enhancement
fee of 0.75%.

     "With the acquisition of Perfect Fit and its affiliates, we expect our 1999
net sales to exceed $250 million," continued Stepan. "We believe the acquisition
of  Perfect  Fit is  another  smart,  accretive  acquisition  that will help our
business expand its leadership position within the personal protective equipment
industry  and  help  us  continue  to  build  our  impressive  track  record  of
outstanding  operating  results.  Since our 1994 fiscal year,  we have  achieved
compound  annual  growth  rates  (excluding  non-recurring,  acquisition-related
adjustments)  of 42.1% in sales,  26.3% in  operating  income,  30.2% in EBITDA,
36.2% in net income and 26.5% in earnings per share."

     Bacou USA, Inc. designs,  manufactures and sells leading brands of products
that protect the sight,  hearing,  respiratory  systems and hands of workers, as
well as related  instrumentation  including vision  screeners,  gas monitors and
test equipment for self-contained  breathing apparatus.  The company's products,
marketed   under  Uvex(R),   Howard   Leight(R),   Perfect  Fit,   Survivair(R),
Pro-Tech(R),  Biosystems,  Titmus(R),  LaserVision and Lase-R  Shield(TM)  brand
names, are sold  principally to industrial  safety  distributors,  fire fighting
equipment  distributors  and optical  laboratories.  News and information  about
Bacou USA is available on the Worldwide Web at http://www.bacouusa.com.

  To receive additional information on Bacou USA, Inc., via fax, at no charge,
                     dial 1-800-PRO-INFO and enter code BAU.

                                       ###

Statements  contained in this press  release that are not  historical  facts are
forward-looking  statements that are made pursuant to the safe harbor provisions
of the Private Securities and Litigation Reform Act of 1995. In addition,  words
such  as  "believes,"  "anticipates,"  "expects"  and  similar  expressions  are
intended  to identify  forward-looking  statements.  Forward-looking  statements
involve  risks  and  uncertainties,  including  but not  limited  to the  timely
development and acceptance of new products,  the impact of competitive  products
and  pricing,   changing  market  conditions,   the  successful  integration  of
acquisitions, continued availability and favorable pricing of raw materials, the
ability of the company and its key vendors to successfully  respond to Year 2000
issues and the other risks detailed in the company's  prospectus filed March 27,
1996,  and  from  time to time in  other  filings.  Actual  results  may  differ
materially from those projected.  These forward-looking statements represent the
company's  judgment  as of the  date of this  release.  The  company  disclaims,
however, any intent or obligation to update these forward-looking statements.

                            (Financial tables follow)

                        BACOU USA, INC. AND SUBSIDIARIES
                      (in thousands, except per share data)
<TABLE>
<CAPTION>
                                                                       Three Months Ended
                                                                           March 31,
                                                                          (unaudited)

Statement of income data:                                            1999               1998
                                                                     ----               ----

<S>                                                                <C>                <C>    
Net sales                                                          $54,575            $49,515
Cost of sales                                                       27,688             24,699
                                                                   -------            -------
Gross profit                                                        26,887             24,816

Operating expenses:
     Selling                                                         8,693              7,948
     General and administrative                                      4,784              4,966
     Research and development                                        1,209                804
     Purchased in-process research and development                    ---               4,680
     Amortization of intangible assets                               2,115              1,484
                                                                   -------             ------
Total operating expenses                                            16,801             19,882
                                                                   -------             ------

Operating income                                                    10,086              4,934

Total other expense                                                  1,550                796
                                                                   -------             ------

Income before income taxes                                           8,536              4,138
Income taxes                                                         3,062              1,402
                                                                   -------             ------

Net income (1)                                                     $ 5,474             $2,736
                                                                   =======             ======

Basic earnings per share (1)                                       $  0.31             $ 0.15
                                                                   =======             ======
Diluted earnings per share (1)                                     $  0.31             $ 0.15
                                                                   =======             ======

Weighted average shares outstanding:
     Basic                                                          17,616             17,594
                                                                   =======             ======
     Diluted                                                        17,786             17,654
                                                                   =======             ======

Other information:
     Depreciation and amortization                                 $ 4,133            $ 3,011
                                                                   =======            =======
     EBITDA (Earnings before interest, taxes, depreciation,
      amortization and  before non-recurring items)                $14,219            $13,909
                                                                   =======            =======
</TABLE>

     (1) The Company completed its acquisition of Howard S. Leight & Associates,
     Inc.  (d/b/a  Howard  Leight  Industries)  on February 27, 1998.  Excluding
     non-recurring  items relating to this acquisition,  net income and earnings
     per share would have been as follows:

<TABLE>
<CAPTION>
                                                                     Three Months Ended
                                                                          March 31,

                                                                    1999                1998
                                                                    ----                ----

<S>                                                                <C>                <C>    
Net income                                                         $ 5,474            $ 6,425
                                                                   =======             ======
Basic and diluted earnings per share                               $  0.31            $  0.36
                                                                   =======             ======
</TABLE>



<PAGE>


                                      BACOU USA, INC. AND SUBSIDIARIES

<TABLE>
<CAPTION>
                                                                            March 31,          December 31,
                                                                              1999                1998
                                                                              ----                ----
Balance Sheet Data (in thousands, except share data; unaudited):
ASSETS

Current assets:
<S>                                                                         <C>                  <C>   
   Cash and cash equivalents                                                $34,208              $1,090
   Trade accounts receivable, net                                            32,647              27,110
   Inventories                                                               37,823              38,246
   Other current assets                                                       2,680               1,251
   Deferred income taxes                                                      1,905               2,138
                                                                              -----               -----
      Total current assets                                                  109,263              69,835
   Property and equipment, net                                               55,084              53,998
   Intangible assets, net                                                   167,829             169,937
                                                                            -------             -------
      Total assets                                                         $332,176            $293,770
                                                                           ========            ========

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
   Current installments of long-term debt                                   $22,857             $15,714
   Accounts payable                                                           6,452               8,959
   Accrued expenses                                                           8,215              12,242
   Income taxes payable                                                       4,227               1,828
                                                                              -----               -----
      Total current liabilities                                              41,751              38,743
Long-term debt                                                              121,428              92,050
Deferred income taxes                                                         6,755               6,311
Other liabilities                                                             2,691               2,754
                                                                              -----               -----
      Total liabilities                                                     172,625             139,858
                                                                            -------             -------

Common stock subject to a put option                                          9,450               9,450
                                                                              -----               -----

Stockholders' equity:
   Preferred stock, $.001 par value, 5,000,000 shares
      authorized, no shares issued and outstanding
   Common  stock,  $.001 par value, 25,000,000 shares
      authorized,  17,621,465 shares in 1999 and 17,610,465 shares
      in 1998 issued and outstanding (including shares subject to
      a put option)                                                              17                  17
   Additional paid-in capital                                                63,423              63,258
   Retained earnings                                                         86,661              81,187
                                                                           --------              ------
   Total stockholders' equity                                               150,101             144,462
                                                                           --------             -------
   Total liabilities and stockholders' equity                              $332,176            $293,770
                                                                           ========            ========
</TABLE>




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission